Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  205 نتائج ل ""Neoplasm, Residual""

فلترة النتائج

Publication : leukemia lymphoma
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Drug exposure and measurable residual disease in chronic lymphocytic leukemia: a systematic review.

  • Authors : Korsholm C; Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.; Bülow C

Subjects: Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/mortality ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Feb; Vol. 66 (2), pp. 229-239. Date of Electronic Publication: 2024 Nov 07.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Single-cell sequencing applications in acute myeloid leukemia.

  • Authors : Lecornec N; Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Université Paris Cité, Paris, France.; Département d'Immuno-Hématologie Pédiatrique, Hôpital Robert-Debré, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.

Subjects: Single-Cell Analysis*/Single-Cell Analysis*/Single-Cell Analysis*/methods ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/genetics ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/diagnosis

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Feb; Vol. 66 (2), pp. 175-189. Date of Electronic Publication: 2024 Nov 04.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Impact of pre-infusion disease burden on outcomes in pediatric relapsed/refractory B-cell lymphoblastic leukemia following anti-CD19 CAR T-cell therapy.

  • Authors : Shang Q; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.; Wang Y

Subjects: Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/methods ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects ; Antigens, CD19*/Antigens, CD19*/Antigens, CD19*/immunology

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Jan; Vol. 66 (1), pp. 54-63. Date of Electronic Publication: 2024 Oct 08.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Predicting relapse in acute lymphoblastic leukemia.

  • Authors : Schwartz MS; University of Colorado Anschutz School of Medicine, Aurora, CO, USA.; Muffly LS

Subjects: Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy ; Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis ; Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Dec; Vol. 65 (13), pp. 1934-1940. Date of Electronic Publication: 2024 Aug 31.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

MRD dynamics during maintenance therapy in 259 patients with nontransplant eligible multiple myeloma.

  • Authors : Cui QQ; Master's Degree Student, Shanxi Medical University, Jinzhong, China.; Li ZH

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/mortality ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Oct; Vol. 65 (10), pp. 1430-1437. Date of Electronic Publication: 2024 May 30.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Advances in the treatment of adults with newly diagnosed B-cell acute lymphoblastic leukemia: the role of frontline immunotherapy-based regimens.

  • Authors : Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kantarjian H

Subjects: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/therapy ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/mortality

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Oct; Vol. 65 (10), pp. 1405-1417. Date of Electronic Publication: 2024 Jun 08.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Risk-adapted treatment for multiple myeloma: assessing the current potential and a roadmap for the future.

  • Authors : Zanwar S; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Kumar S

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/diagnosis ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/mortality

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Apr; Vol. 66 (4), pp. 573-583. Date of Electronic Publication: 2024 Dec 22.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

FISH combined with RT-PCR facilitates classification of Chinese adult patients with B-other ALL through improved identification of ZNF384 rearrangement.

  • Authors : Li Q; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Xing S

Subjects: In Situ Hybridization, Fluorescence* ; Gene Rearrangement* ; Trans-Activators*/Trans-Activators*/Trans-Activators*/genetics

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Mar; Vol. 66 (3), pp. 507-515. Date of Electronic Publication: 2024 Nov 09.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemia.

  • Authors : Ngo D; Department of Pharmacy, City of Hope, Duarte, CA, USA.; Tinajero J

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/adverse effects ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/administration & dosage

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Dec; Vol. 65 (13), pp. 2016-2024. Date of Electronic Publication: 2024 Aug 18.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Bridging the gap: understanding contemporary autopsies in acute leukemia by comparing ante-mortem and post-mortem profiles.

  • Authors : Suresh D; Department of Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.; Rastogi P

Subjects: Autopsy* ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/pathology ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/mortality

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Nov; Vol. 65 (11), pp. 1675-1690. Date of Electronic Publication: 2024 Jul 01.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  205 نتائج ل ""Neoplasm, Residual""